Literature DB >> 6318711

Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).

T Takimoto, M Kamide, R Umeda.   

Abstract

Primary nasopharyngeal carcinoma (NPC) cells were fused to hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-defective cells derived from adenoid tissues using Sendai virus. Some of the fused cells developed into epithelial-like hybrid cells in a selective HAT medium. The hybrid cells (NPC-KT) were Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive cells. There have been no reports on the establishment of EBNA-positive epithelial cell lines derived from NPC. Thus, the epithelial-like hybrid cells might serve as an in vitro model for studying the biologic activity of NPC-associated EBV.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6318711     DOI: 10.1007/bf00454266

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  11 in total

1.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups.

Authors:  W Henle; G Henle; H C Ho; P Burtin; Y Cachin; P Clifford; A de Schryver; G de-Thé; V Diehl; G Klein
Journal:  J Natl Cancer Inst       Date:  1970-01       Impact factor: 13.506

2.  SELECTION OF HYBRIDS FROM MATINGS OF FIBROBLASTS IN VITRO AND THEIR PRESUMED RECOMBINANTS.

Authors:  J W LITTLEFIELD
Journal:  Science       Date:  1964-08-14       Impact factor: 47.728

3.  Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Authors:  L J Old; E A Boyse; H F Oettgen; E D Harven; G Geering; B Williamson; P Clifford
Journal:  Proc Natl Acad Sci U S A       Date:  1966-12       Impact factor: 11.205

4.  Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Authors:  G Henle; W Henle
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.

Authors:  D P Huang; J H Ho; W Henle; G Henle
Journal:  Int J Cancer       Date:  1974-11-15       Impact factor: 7.396

7.  [Experimental studies on viral etiology of Epstein-Barr (EBV) in nasopharyngeal carcinoma (NPC):establishment of EBV infection on human epithelial derived from nasopharyngeal tissue (author's transl)].

Authors:  T Takimoto
Journal:  Nihon Jibiinkoka Gakkai Kaiho       Date:  1979-02-20

8.  Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx.

Authors:  D P Huang; J H Ho; Y F Poon; E C Chew; D Saw; M Lui; C L Li; L S Mak; S H Lai; W H Lau
Journal:  Int J Cancer       Date:  1980-08       Impact factor: 7.396

9.  Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination.

Authors:  M Andersson-Anvret; N Forsby; G Klein; W Henle
Journal:  Int J Cancer       Date:  1977-10-15       Impact factor: 7.396

10.  Nasopharyngeal carcinoma (NPC). I. Types of cultures derived from tumour biopsies and non-tumorous tissues of Chinese patients with special reference to lymphoblastoid transformation.

Authors:  G De-Thé; H C Ho; H C Kwan; C Desgranges; M C Favre
Journal:  Int J Cancer       Date:  1970-09-15       Impact factor: 7.396

View more
  17 in total

1.  The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.

Authors:  H Chen; J M Lee; Y Wang; D P Huang; R F Ambinder; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  The Epstein-Barr virus protein BMRF1 activates gastrin transcription.

Authors:  Elizabeth A Holley-Guthrie; William T Seaman; Prasanna Bhende; Juanita L Merchant; Shannon C Kenney
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene.

Authors:  Asako Kawaguchi; Kyosuke Kanai; Yukio Satoh; Chizu Touge; Keiko Nagata; Takeshi Sairenji; Yoshitsugu Inoue
Journal:  Virus Genes       Date:  2009-01-20       Impact factor: 2.332

4.  Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.

Authors:  H Sato; T Takimoto; S Tanaka; J Tanaka; N Raab-Traub
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

5.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

6.  A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

8.  Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.

Authors:  H Sato; T Takimoto; J S Pagano; N Raab-Traub
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.

Authors:  A L Adamson; D Darr; E Holley-Guthrie; R A Johnson; A Mauser; J Swenson; S Kenney
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

10.  Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes.

Authors:  Michael J Strong; Melody Baddoo; Asuka Nanbo; Miao Xu; Adriane Puetter; Zhen Lin
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.